Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma

被引:8
|
作者
Korhonen, Niina [1 ,2 ]
Ylitalo, Leea [1 ,2 ,3 ]
Luukkaala, Tiina [4 ]
Itkonen, Julius [1 ,2 ]
Haihala, Henni [1 ,2 ]
Jernman, Juha [5 ,6 ]
Snellman, Erna [1 ,2 ]
Palve, Johanna [2 ,7 ]
机构
[1] Tampere Univ, Tampere Univ Hosp, Dept Dermatol & Allergol, Tampere, Finland
[2] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[3] Univ Helsinki, Skin Canc Unit, Dept Dermatol, Cent Hosp, Helsinki, Finland
[4] Tampere Univ, Tampere Univ Hosp & Hlth Sci, Res Dev & Innovat Ctr, Fac Social Sci, Tampere, Finland
[5] Tampere Univ, Dept Pathol, Tampere, Finland
[6] Fimlab Labs, Tampere, Finland
[7] Tampere Univ, Tampere Univ Hosp, Dept Plast Surg, Tampere, Finland
关键词
Cutaneous squamous cell carcinoma; Basal cell carcinoma; Cutaneous melanoma; Actinic keratosis; Bowen's disease; ACTINIC KERATOSIS; RISK; POPULATION; PREVALENCE; GUIDELINES; DIAGNOSIS; CONSENSUS;
D O I
10.1007/s00403-020-02114-w
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The incidence of keratinocyte carcinomas is increasing worldwide and currently there is no standardised strategy for the follow-up of patients with multiple tumours. The objective of this study was to assess the prevalence of premalignant lesions, i.e., actinic keratosis and Bowen's disease, as well as basal cell carcinoma (BCC) and cutaneous melanoma (CM) among patients with cutaneous squamous cell carcinoma (cSCC). Pathology database search was performed to identify all cSCC patients diagnosed in the Pirkanmaa region of Finland in 2006-2015. Details of the patients and tumours were obtained through medical record review. The cohort consisted of 774 patients with 1131 cSCC tumours. Overall 559 patients (72%) had premalignant lesions. A total of 316 patients (41%) had BCC and 52% of these (n = 164) had more than one BCC tumour. 50 patients (6%) had CM. Overall 180 cSCC patients (23%) had no premalignant changes, BCC or CM. The median age of these patients was 6 years less than that of the patients with premalignant lesions (p < 0.001) or BCC (p < 0.001). The invasion depth of the tumours was deeper in the patients with only cSCC (median 3 mm, interquartile range 2-6) than in those with premalignant lesions or BCC (median 2 mm, interquartile range 1-3),p < 0.001. CSCC patients have a high risk of developing multiple skin cancers and need long-term follow-up.
引用
收藏
页码:879 / 884
页数:6
相关论文
共 50 条
  • [1] Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma
    Niina Korhonen
    Leea Ylitalo
    Tiina Luukkaala
    Julius Itkonen
    Henni Häihälä
    Juha Jernman
    Erna Snellman
    Johanna Palve
    [J]. Archives of Dermatological Research, 2021, 313 : 879 - 884
  • [2] Basal Cell Carcinoma, Squamous Cell Carcinoma, and Cutaneous Melanoma in Skin of Color Patients
    Hogue, Latrice
    Harvey, Valerie M.
    [J]. DERMATOLOGIC CLINICS, 2019, 37 (04) : 519 - +
  • [3] Squamous cell carcinoma of the penis: Premalignant lesions
    Horenblas, S
    von Krogh, G
    Cubilla, AL
    Dillner, J
    Meijer, CJLM
    Hedlund, PO
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 : 187 - 188
  • [4] Risk of basal cell and squamous cell carcinoma in persons with prior cutaneous melanoma
    Kroumpouzos, G
    Konstadoulakis, MM
    Cabral, H
    Karakousis, CP
    [J]. DERMATOLOGIC SURGERY, 2000, 26 (06) : 547 - 550
  • [5] Inverse genetic risk between cutaneous melanoma, basal cell carcinoma, squamous cell carcinoma and vitiligo
    Rashid, S.
    Klebanov, N.
    Shaughnessy, M.
    Daly, M.
    Artomov, M.
    Tsao, H.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S110 - S110
  • [6] Acceptable delay between diagnosis and treatment of melanoma, cutaneous squamous cell carcinoma, and basal cell carcinoma
    Alam, M.
    Etzkorn, J.
    Albertini, J. G.
    Bordeaux, J.
    Council, L.
    Maher, J. A.
    Nehal, K. S.
    Brodland, D. G.
    Haas, A. F.
    Ibrahim, S. A.
    Keimig, E.
    Poon, E.
    Worley, B.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S71 - S71
  • [7] Surgical Considerations in Advance Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, and Cutaneous Melanoma: a Head and Neck Perspective
    Zhou T.C.
    Eskander A.E.
    Old M.O.
    Kang S.Y.
    Teknos T.N.
    [J]. Current Otorhinolaryngology Reports, 2018, 6 (2) : 140 - 150
  • [9] Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face
    Feller, L.
    Khammissa, R. A. G.
    Kramer, B.
    Altini, M.
    Lemmer, J.
    [J]. HEAD & FACE MEDICINE, 2016, 12
  • [10] Radiotherapy in Cutaneous Squamous Cell and Basal Cell Carcinoma
    Gharzai, Laila A.
    Mierzwa, Michelle L.
    [J]. FACIAL PLASTIC SURGERY, 2020, 36 (02) : 180 - 185